Brief: T2 Biosystems Affirms Plans To Add Candida Auris Detection To The FDA-Cleared T2candida Panel
23/03/2023 13:20
March 23 (Reuters) - T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS AFFIRMS PLANS TO ADD CANDIDA AURIS DETECTION
TO
THE FDA-CLEARED T2CANDIDA PANEL
Source text for Eikon: ID:nGNX2cxsY3
Further company coverage: TTOO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor